American College of Cardiology10d
Semaglutide and BP, HF Risk Assessment Using Biomarkers, DAPT After Drug-Eluting Stenting in ACS
In this week’s View, Dr. Eagle looks at an individual patient data meta-analysis of semaglutide and blood pressure (BP). He ...
American College of Cardiology11d
Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial
The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements ...
American College of Cardiology10d
Ten Points to Remember From the Recent Scientific Statement on Aortopathy Management in Children
Early genetic testing. Early genetic testing in children with aortopathy enables personalized care and early appropriate ...
American College of Cardiology3d
Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials
The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one conducted in a general primary-care population and ...
American College of Cardiology5d
Intra- and Post-Operative Management of Conduits for CABG: Key Points
The following are key points to remember from a European clinical consensus statement on intra-operative and post-operative management of conduits for coronary artery bypass grafting (CABG): ...
American College of Cardiology5d
Intensive Early and Sustained Lowering of Non–HDL-C
After an MI, the rates of cardiovascular outcomes and mortality were lowest among patients achieving the largest reductions in non–HDL-C and the lowest non–HDL-C levels down to ∼2 mmol/L. The lowest ...
American College of Cardiology5d
ACC CardiaCast: Pulse Check: What’s New in Hypertension Management for the Pharmacist CV Team Professional?
Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based ...
American College of Cardiology11d
ACC CardiaCast: Pulse Check: What’s new in AFib for the Pharmacists CV Team Professional?
Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based ...
American College of Cardiology4d
Efficacy and Safety of Olezarsen in Managing Hypertriglyceridemia: Insights From the BRIDGE–TIMI 73a Trial
The BRIDGE–TIMI 73a (Bridge–TIMI [Thrombolysis in Myocardial Infarction] 73a) trial data demonstrated that olezarsen significantly reduced triglyceride (TG) levels by 49.3% at the 50 mg dose and by 53 ...
American College of Cardiology8d
Arrhythmias and Autonomic Dysfunction With COVID-19: Key Points
The following are key points to remember from an American Heart Association scientific statement on arrhythmias and autonomic dysfunction associated with coronavirus disease 2019 (COVID-19): ...
American College of Cardiology7d
ACC CardiaCast: AFib Updates: Beat the Rhythm, Block the Stroke
In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to ...
American College of Cardiology7d
Predicting Sudden Cardiac Death After Acute MI
Peek N, Hindricks G, Akbarov A, et al., on behalf of the PROFID Consortium. The analysis pooled 20 data sets with 140,204 post-MI patients containing information on demographics, medical history, ...